CVS - CVS Health Corporation

NYSE - NYSE Delayed price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 598.9B
Enterprise value 3181.61B
Trailing P/E 21.41
Forward P/E 110.65
PEG ratio (5-yr expected) 13.76
Price/sales (ttm)0.41
Price/book (mrq)1.58
Enterprise value/revenue 30.75
Enterprise value/EBITDA 611.53

Trading information

Stock price history

Beta (5Y monthly) 0.87
52-week change 317.14%
S&P500 52-week change 325.98%
52-week high 377.03
52-week low 351.72
50-day moving average 374.14
200-day moving average 365.68

Share statistics

Avg vol (3-month) 36.58M
Avg vol (10-day) 36.32M
Shares outstanding 51.3B
Float 1.3B
% held by insiders 10.18%
% held by institutions 179.71%
Shares short (30 Dec 2019) 420.25M
Short ratio (30 Dec 2019) 43.74
Short % of float (30 Dec 2019) 41.56%
Short % of shares outstanding (30 Dec 2019) 41.56%
Shares short (prior month 28 Nov 2019) 420.28M

Dividends & splits

Forward annual dividend rate 42
Forward annual dividend yield 42.63%
Trailing annual dividend rate 32.00
Trailing annual dividend yield 32.63%
5-year average dividend yield 42.33
Payout ratio 459.70%
Dividend date 302 Feb 2020
Ex-dividend date 421 Jan 2020
Last split factor 22:1
Last split date 306 Jun 2005

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2018
Most-recent quarter (mrq)29 Sep 2019

Profitability

Profit margin 1.84%
Operating margin (ttm)4.80%

Management effectiveness

Return on assets (ttm)4.15%
Return on equity (ttm)8.97%

Income statement

Revenue (ttm)243.33B
Revenue per share (ttm)193.81
Quarterly revenue growth (yoy)36.60%
Gross profit (ttm)30.88B
EBITDA 15.75B
Net income avi to common (ttm)4.46B
Diluted EPS (ttm)3.55
Quarterly earnings growth (yoy)10.10%

Balance sheet

Total cash (mrq)7.53B
Total cash per share (mrq)5.79
Total debt (mrq)89.68B
Total debt/equity (mrq)142.50
Current ratio (mrq)0.92
Book value per share (mrq)48.13

Cash flow statement

Operating cash flow (ttm)12.69B
Levered free cash flow (ttm)15.67B